It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

Susan Sharfstein, a professor at UAlbany's College of Nanotechnology, Science and Engineering, partners with DeepSeq.AI on a ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

Indian contract drugmaker Anthem Biosciences files for $397 million IPO amid booming Indian market for public offerings.

GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

Robust process development is essential in pharmaceutical manufacturing, optimizing drug discovery and ensuring regulatory ...

The start-up – founded by investment group Flagship Pioneering – said that OPL-0401 did not meet either the primary or ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

A team led by researchers at the University of Toronto has created a platform, called SIMPL2, that improves the study of ...